data sciences

Setting the standard for cell and gene therapy manufacturing success

Cell therapy manufacturing and gene therapy manufacturing pose distinct challenges. We’ve helped dozens of advanced therapy innovators conquer them—building the largest advanced therapy manufacturing footprint in the world, while streamlining the inherent complexity to speed product to market without sacrificing quality or safety.

40+
FACILITY BUILDS
$4B
TOTAL SPEND
80+
PARTNERS
2
FIRST-EVER
FDA, EMA APPROVED THERAPIES INDUSTRIALIZED

Harness our pioneering expertise at every critical juncture

Precision for Medicine’s cell and gene therapy capabilities expanded with the acquisition of Project Farma to offer market leading expertise and practices that address the entire manufacturing lifecycle—from technical operations strategy to manufacturing execution—honed through work with leading advanced therapy companies, startups, academics, and investment firms.

Technical Operations Strategy

The complexity of both gene and cell therapy manufacturing often leads to bottlenecks that derail timelines. We provide strategic insights born from our pioneering experience in manufacturing execution to ensure success.

  • Due diligence, pipeline evaluation, and mobilization
  • Make-vs-buy business case analysis and execution
  • Business infrastructure startup and support
  • GMP infrastructure startup and support
  • Program management
Manufacturing Execution

Successful gene and cell therapy manufacturing demands a range of highly specialized expertise, spanning areas from complex facility builds to stringent engineering requirements. We deliver on every front.

  • Capital projects, facility builds, and tech transfers
  • Quality, regulatory, and compliance
  • Engineering and automation
  • Validation
  • Reliability, maintenance, and asset management

Harness our pioneering expertise at every critical juncture

Precision for Medicine’s cell and gene therapy capabilities expanded with the acquisition of Project Farma to offer market leading expertise and practices that address the entire manufacturing lifecycle—from technical operations strategy to manufacturing execution—honed through work with leading advanced therapy companies, startups, academics, and investment firms.

Technical Operations Strategy

The complexity of both gene and cell therapy manufacturing often leads to bottlenecks that derail timelines. We provide strategic insights born from our pioneering experience in manufacturing execution to ensure success.

  • Due diligence, pipeline evaluation, and mobilization
  • Make-vs-buy business case analysis and execution
  • Business infrastructure startup and support
  • GMP infrastructure startup and support
  • Program management
Manufacturing Execution

Successful gene and cell therapy manufacturing demands a range of highly specialized expertise, spanning areas from complex facility builds to stringent engineering requirements. We deliver on every front.

  • Capital projects, facility builds, and tech transfers
  • Quality, regulatory, and compliance
  • Engineering and automation
  • Validation
  • Reliability, maintenance, and asset management

We wrote the book. And we’re willing to share.

Whether you are preparing to manufacture cell or gene therapies, you have a host of questions. Our Advanced Therapy Manufacturing Playbook can answer them.

We wrote the book. And we’re willing to share.

Whether you are preparing to manufacture cell or gene therapies, you have a host of questions. Our Advanced Therapy Manufacturing Playbook can answer them.

Partner with the leader in development, manufacturing, and commercialization for cell and gene therapies

Delivering a cell or gene therapy to market requires a nuanced, comprehensive, and integrated approach. That’s why all Precision clients have access to ADVANCE. The Precision ADVANCE cell and gene therapy collective brings together our unique expertise and capabilities across the continuum of early development, biological manufacturing, and commercialization. These interconnected services support and protect the uninterrupted advance of your therapy.

Partner with the leader in development, manufacturing, and commercialization for cell and gene therapies

Delivering a cell or gene therapy to market requires a nuanced, comprehensive, and integrated approach. That’s why all Precision clients have access to ADVANCE. The Precision ADVANCE cell and gene therapy collective brings together our unique expertise and capabilities across the continuum of early development, biological manufacturing, and commercialization. These interconnected services support and protect the uninterrupted advance of your therapy.

Discover how our cell and gene therapy manufacturing can advance your clinical or commercial development program

Discover how our cell and gene therapy manufacturing can advance your clinical or commercial development program